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Abstract 
Low birthweight is a risk factor for neonatal mortality and adverse metabolic health, both associated with 
inadequate prenatal adipose tissue development. Here we investigated the impact of maternal 
undernutrition on expression of genes regulating fetal perirenal adipose tissue (PAT) development and 
function at gestation days 89 and 130 (term=145d). Singleton fetuses were taken from adolescent ewes 
fed control (C) intake to maintain adiposity throughout pregnancy or undernourished (UN) to maintain 
conception weight but deplete maternal reserves (n=7/group). Fetal weight was independent of maternal 
intake at day 89 but by day 130 fetuses from UN dams were 17% lighter with lower PAT mass containing 
fewer unilocular adipocytes. Relative PAT expression of IGF1, IGF2, IGF2R and peroxisome-
proliferator-activated receptor-gamma (PPARG) mRNA was lower in UN than in C, predominantly at day 
89. Independent of maternal nutrition, PAT gene expression of PPARG, glycerol-3-phosphate 
dehydrogenase, hormone sensitive lipase, leptin, uncoupling protein-1 and prolactin receptor increased 
and IGF1, IGF2, IGF1R, IGF2R decreased between 89 and 130 days. Fatty acid synthase and lipoprotein 
lipase (LPL) mRNAs were not influenced by nutrition or stage of pregnancy. Females had greater LPL 
and leptin mRNA than males, and LPL, leptin and PPARG mRNAs were decreased by UN at day 89 in 
females only.  PAT gene expression correlations with PAT mass were stronger at day 89 than day 130. 
These data suggest that key genes regulating adipose tissue development and function are active from 
mid-gestation when they are sensitive to maternal undernutrition. This leads to reduced fetal adiposity by 
late pregnancy. 
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Introduction 
Prenatal growth restriction leading to low birthweight remains a global health issue and in 2013 
was estimated to impact more than 22 million babies (16%) born, with the highest incidence in Southeast 
Asia and Africa (http://data.unicef.org/nutrition/low-birthweight). Maternal malnutrition involving 
deficits in macro- and micro-nutrients remains the major cause of low birthweight in developing countries 
(http://www.countdown2015mnch.org/documents/2013Report/Countdown_2013-
Update_withprofiles.pdf).  Affected neonates have increased risk of neonatal mortality whereas surviving 
infants have greater risk of life-restricting complications involving stunted growth, poor immune function 
and low educational attainment (Raqib et al. 2007; Longo et al. 2013; Christian et al. 2014). Furthermore, 
low birthweight predicts metabolic syndrome and obesity in adulthood, and these consequences are 
exacerbated if the postnatal environment is nutrient-rich such as occurs in populations undergoing 
economic transition (Jain & Singhal 2012).  Similarly, in agriculturally important mammals (ruminants, 
pigs) there is evidence that maternal undernutrition is the primary determinant of poor prenatal growth, 
with reductions in birthweight dependent on timing, duration and severity of the nutritional insult and age 
and/or parity of the dam (Luther et al. 2005;Wu et al. 2006). For these species low birthweight negatively 
impacts commercially important traits including neonatal survival and carcass fat content, with decreased 
financial returns for the producer (Greenwood et al. 2010; Nissen & Oksbjerg 2010). 
In precocial mammals appropriate prenatal adipose tissue development is essential for adequate 
thermoregulation at birth to ensure immediate survival. In addition, adipose tissue is central to energy 
metabolism throughout the life-course (Klaus 2004; Galic et al. 2010), and derangements in its early 
development potentially impact body composition in later life. Accordingly, adipose tissue is considered 
to be a key target of developmental programming by maternal and/or fetal undernutrition (Sarr et al. 
2012; Lukaszewski et al. 2013). In humans and sheep adipose tissue is present from mid-gestation 
onwards with most fat deposition occurring in the final third of pregnancy predominately in the perirenal 
region (Moragas & Torán 1983; Gemmell & Alexander 1978). At mid-gestation perirenal adipose tissue 
(PAT) is characterised by rapid multiplication of precursor cells or pre-adipocytes (Pope et al. 2014) and 
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by late pregnancy this fat depot contains cells with the appearance of both white (unilocular) and brown 
(multilocular) adipocytes (Gemmell & Alexander 1978); these stages thereby reflect key windows in fetal 
fat development. In adults unilocular adipocytes are the major site of lipid storage and leptin secretion, 
and similarly in late gestation ovine fetuses plasma leptin correlates with unilocular fat mass when 
maternal nutrient intake is at or above maintenance requirements (Mühlhäusler et al. 2002). In contrast, 
multilocular adipocytes are predominantly associated with young animals; they are mitochondria-rich and 
play an essential role in neonatal thermogenesis via a unique uncoupling protein (UCP1) that burns fatty 
acids and glucose to release heat (Symonds 2013). Maternal undernutrition via its negative impact on 
fetal nutrient availability may alter relative proportions of white and brown fat in the fetus, with 
implications for subsequent survival and body composition, but this hypothesis has not been tested. 
Published studies have examined selected molecular markers of adipose tissue growth, differentiation and 
function in PAT of late gestation sheep fetuses whose mothers were undernourished during specific 
windows of gestation, but no clear consensus emerged regarding the impact of nutrition on fetal growth, 
PAT depot mass or gene expression (Symonds et al. 1998; Bispham et al. 2003; Budge et al. 2004; Lie et 
al. 2013).  
Here we address this deficit by examining PAT gene expression at both mid and late pregnancy in 
a sheep model where maternal undernutrition throughout gestation reduced fetal weight, carcass fat 
content and PAT mass by late pregnancy (Luther et al. 2007). We examined genes involved in adipocyte 
proliferation and differentiation, namely IGF1, IGF2, IGF1R, IGF2R (Holly et al. 2006; Kleiman et al. 
2013), and peroxisome-proliferator-activated receptor-gamma (PPARG) a transcriptional regulator 
playing a central role in adipocyte differentiation as well as co-ordinating genes involved in lipid 
deposition and metabolism (Semple et al. 2006). These include lipogenic genes such as lipoprotein lipase 
(LPL), which enhances fatty acid uptake into adipocytes, fatty acid synthase (FASN), which catalyses 
fatty acid synthesis, and glycerol-3-phosphate dehydrogenase (G3PDH), which is involved in 
glyceroneogenesis, and lipolytic genes such as hormone sensitive lipase (HSL), which is involved in 
hydrolysis of stored triglycerides to release non-esterified fatty acids (NEFA). We also measured gene 
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expression for leptin, because previous studies suggest it reflects the proportion of white adipose tissue in 
the fetus (Yuen et al. 2003), and for UCP1 and prolactin receptor (PRLR) as markers of brown adipose 
tissue function (Pope et al. 2014). Accordingly, a secondary objective herein was to quantify the 
proportion of unilocular and multilocular cells in PAT of fetuses from undernourished versus optimally-
nourished dams.  
This study tested the hypothesis that molecular markers of fetal adipose tissue development are 
temporally sensitive to maternal undernutrition and are associated with the resulting late gestation lean 
fetal phenotype.     
 
Materials and Methods 
Animals and sample derivation 
All procedures were licensed under the UK Animals (Scientific Procedures) Act 1986 and 
approved by local Ethical Review Committee. Day 4 embryos, recovered from adult ewes inseminated by 
a single sire, were transferred synchronously in singleton into adolescent recipients, as described 
previously (Wallace et al. 1997). Details of genotype, age, weight and adiposity of the animals, together 
with full details of experimental design and diet composition have been presented previously (Luther et 
al. 2007). Briefly, recipients of equivalent age, weight and adiposity were individually offered optimal 
control (C) or low quantity of the same complete diet (~0.7 x C intake) following embryo transfer.  The C 
dietary level aimed to maintain normal maternal adiposity throughout gestation (promoting liveweight 
gain ~50g/day) and to provide 100% nutrient requirements of the adolescent sheep carrying a singleton 
fetus according to stage of pregnancy (AFRC 1993). The low dietary intake was calculated to maintain 
maternal liveweight at the initial value, thereby depleting maternal reserves throughout gestation as she 
attempts to meet the nutrient requirements of the developing conceptus: these dams were considered 
undernourished (UN). The level of feed offered was reviewed three-times weekly and adjusted as 
appropriate according to weekly bodyweight change data.  Maternal body condition was subjectively 
assessed on a five-point scale fortnightly by the same highly experienced operator (1 = emaciated, 5 = 
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obese; Russel et al. 1969). This score provides an external measure of adiposity, and is highly correlated 
with maternal carcass fat determined by chemical analysis (Wallace et al. 1999).  Ultrasonography at 45d 
gestation revealed 28 viable pregnancies.         
Immediately before necropsy maternal venous blood was sampled and the plasma used to confirm 
metabolic status: namely glucose, insulin and NEFA concentrations. Ewes were killed on either d89 or 
130 gestation (n=7/ group/ stage; term =145 days) by i.v. sodium pentobarbitone (20ml Euthesate; 200mg 
pentobarbitone/ml; Willows Francis Veterinary, Crawley, UK) and exsanguination.  The gravid uterus 
was weighed and opened, and fetal blood sampled by cardiac puncture immediately before administering 
intracardiac sodium pentobarbitone (3ml Euthesate); this plasma was analysed for glucose and insulin. 
The fetus was dried and weighed. PAT was weighed and samples either snap-frozen in isopentane chilled 
by liquid nitrogen and stored at -80oC until gene expression analysis (d89 and 130) or fixed in 10% 
neutral buffered formalin and embedded in paraffin for histological quantification of adipocytes (d130 
only). Intact placentomes were dissected and weighed. The maternal carcass was weighed to confirm the 
effectiveness of nutritional treatments. The fat content of fetal carcasses was determined by chemical 
analysis (Wallace et al. 2006).  
  
Plasma analyses 
Maternal plasma NEFA was measured using an automated clinical analyzer with kits supplied by 
the manufacturer (Labmedics, Manchester, UK), with variation between duplicates <5%. Maternal and 
fetal insulin was measured by radioimmunoassay (MacRae et al. 1991; duplicate variation <10%) and 
glucose by dual-biochemistry analyser (YSI model 2700, Yellow Springs, OH, USA; duplicate variation 
<3%). 
 
Fetal adipocyte histology 
The method used to quantify the density of unilocular and multilocular cells in fetal PAT matched 
that of Mühlhäusler et al. (2002). Sections were cut (5µm), dried overnight, stained with haematoxylin 
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and eosin and viewed at 200x magnification using a Leica microscope. Twelve separate complete fields 
of view per animal, ~1mm apart on a single section, were captured by digital camera and the images 
analysed using Image-Pro Plus (version 4.5.1, Media Cybernetics, Inc., Silver Spring, MD, USA). 
Standard point counting techniques (Weibel 1979) were employed: a standard grid was used to determine 
the adipose tissue component (i.e. unilocular or multilocular cell) falling below each of 35 grid points per 
image, thus totalling 420 points per animal. The volume density (Vd) of each cell type was calculated as 
Vd=N/T, where N is the number of points falling on unilocular or multilocular cells, and T is the total 
number of points counted. The total mass of the unilocular or multilocular component was calculated by 
multiplying the Vd of each component by the PAT mass. Relative unilocular (or multilocular) fat mass 
(g/kg fetus) was calculated by dividing by fetal weight.    
       
Quantitative real-time reverse transcription-polymerase chain reaction analysis 
Messenger RNA for genes involved in adipocyte proliferation (IGF1, IGF2, IGF1R, IGF2R) 
differentiation and function (PPARG, G3PDH, LPL, FAS, HSL, UCP1, PRLR, leptin) in fetal PAT were 
measured by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) using 
probe and primer sets for sheep-specific sequences of these genes as previously described (Matsuzaki et 
al. 2006; Wallace et al. 2014). Briefly total RNA was extracted from 100mg frozen PAT using RNeasy 
Lipid Tissue Mini Kit (Qiagen, Crawley, West Sussex, UK). The quality and quantity of total RNA were 
determined via capillary electrophoresis using an Agilent 2100 Bioanalyzer (Agilent Technologies, 
Wilmington, DE, USA). Real-time RT-PCR reagents, probes, and primers were purchased from and used 
as recommended by Applied Biosystems (Warrington, UK). For each sample 54ng total RNA was 
subjected to reverse transcription (RT) in triplicate to generate first-strand cDNA using Taqman Reverse 
Transcription Reagents and Multiscribe Reverse Transcriptase. Polymerisation and amplification 
reactions for each RT sample were performed in duplicate in 20µl final volume using the Applied 
Biosystems 7500 Fast Real-Time PCR system. Quantification was performed using a relative standard 
curve method with serial dilutions of reference standard cDNA generated from RNA pooled from PAT of 
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control and undernourished fetuses (3/stage/group). Individual mRNA levels of genes of interest were 
expressed relative to the sample’s own internal 18S RNA, determined using human 18S Pre-developed 
TaqMan Assay Reagents. Samples were randomised to ensure that each nutritional treatment and sex was 
represented in each of four 96-well plates. Also a quality control sample generated from the above RNA 
pool was run on each plate and used to calculate inter- and intra-assay coefficients of variation (cov). 
Intra-plate cov varied from 3.9 to 6.5 % (mean±sem, 5.3±0.23) while inter- plate cov varied from 0.76 to 
10.76 % (7.1±0.80).   
 
Statistical analysis 
The power calculation carried out for the original study was based on the prediction that maternal 
undernutrition would impact fetal growth by the late gestation time-point. Accordingly seven animals per 
group were selected so that the experiment would have 80% power to detect (at 5% significance) a 20% 
change in fetal weight of 870g assuming animal variability of 515g. This was based on fetal weight data 
obtained from control-fed adolescent ewes of the same genotype, with identical paternal genetics and at 
the same stage of gestation. Statistical comparisons were made using Minitab (Minitab 16, Minitab Inc., 
State College, PA). ANOVA (general linear model, GLM) was used to determine effects of maternal 
nutrition and gestational stage, and their interaction, on maternal and fetal phenotype (Table 1) and on 
fetal PAT gene expression (Table 3). Post-hoc comparisons used Tukey’s method when one of the main 
effects or their interaction was significant. We had no control over the sex of the embryo/fetus and 
accordingly the study was not originally powered to examine gender effects; however, sex-specific effects 
were apparent upon initial examination of the data and so we additionally included sex as a factor in a 
second 3-factor ANOVA (nutrition*stage*sex, and all possible interactions) and present relevant findings 
separately (text and Figure 2).  Paired Student’s t tests were used to determine differences in adipocyte 
cell type at d130 (Table 2). Pearson product-moment correlation was used to explore relationships 
between variables where indicated. Values are group mean ± sem throughout, statistical significance was 
taken as P<0.05 and a trend was indicated where P=0.06-0.1. 
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 Results 
Maternal and fetal phenotype  
By design maternal liveweight (42.9±0.41kg) and adiposity score (2.3±0.02) were equivalent 
between groups at embryo transfer and thereafter dams receiving a control (C) intake maintained their 
initial adiposity score until necropsy at gestational d89 or 130 (Table 1). In contrast, the external adiposity 
score of underfed (UN) dams gradually decreased, with the changes equivalent to average losses of 6.2 
and 8.8% body fat at d89 and 130, respectively (Russel et al. 1969). Maternal liveweight and carcass 
mass had diverged by d89, with the difference between nutritional groups increased by d130. The 
relatively catabolic state of UN dams was mirrored by low plasma insulin and glucose, and by late 
pregnancy plasma NEFA was increased in UN versus C dams.  
Fetal weight was independent of maternal dietary intake at d89 but by d130 fetuses from UN dams 
were 17% lighter than those in C dams (Table 1), although brain growth was preserved as indicated by 
higher fetal-weight specific brain weight (12.0±0.39 vs. 9.9±0.35g/kg, P<0.01) as well as greater brain: 
liver weight ratios (Table 1). Fetal plasma insulin and glucose were independent of maternal nutrition at 
d89 but there were trends towards lower insulin and glucose in the UN group at d130. Total placentome 
weight was not affected by maternal nutrition at either time-point (Table 1). 
 
Fetal adiposity  
Absolute PAT mass increased >12-fold between gestational d89 and 130 and was lower in fetuses 
of UN dams at the late gestation time-point (Table 1). Moreover, PAT mass was positively related to fetal 
weight at both gestational ages (r=0.632, P=0.015 and r=0.738, P=0.003, n=14 at d89 and 130) and 
accordingly fetal weight-specific PAT mass was also negatively impacted by maternal undernutrition. At 
gestation d130, both absolute and fetal weight-specific unilocular fat cell mass was lower in fetuses from 
UN versus C dams (Table 2), but there were no significant effects of nutrition on multilocular cell mass. 
Representative images are presented in Figure 1. The relative proportion (volume density) of unilocular 
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versus multilocular cells was equivalent within the C group but UN fetuses had more multilocular than 
unilocular cells (P<0.05). Irrespective of maternal nutrition, absolute and relative fetal unilocular fat mass 
was positively associated with carcass fat percentage (n=14; r=0.806, P=0.001 and r=0.763, P=0.001, 
Figure 1c). Multilocular fat cell mass was unrelated to fetal carcass fat percentage, but total multilocular 
fat mass was positively associated with fetal weight (r=0.605, P=0.022, n=14 Figure 1d), primarily due to 
the UN group (r=0.787, P=0.036, n=7).  
  
Perirenal fat gene expression 
The 2-factor ANOVA revealed an increase in PPARG mRNA expression in PAT as gestation 
progressed, while the stage x nutrition interaction reflected lower PPARG mRNA abundance in the UN 
group at gestational d89 but not at d130 (Table 3). G3PDH and HSL mRNA expression increased 2-3 fold 
between d89 and 130 irrespective of maternal nutrition, whereas LPL and FAS mRNA levels were 
independent of both gestational age and nutrition. UCP1 and PRLR mRNA were virtually undetectable at 
d89 and independent of maternal nutrition at d130. In contrast, gene expression for IGF1, IGF2 and their 
receptors was robustly greater at d89 than at d130, and  these genes were impacted by maternal nutrition, 
largely due to lower expression in UN fetuses at d89. PAT leptin mRNA was influenced by stage of 
pregnancy (d130>89), with a trend for lower expression in UN fetuses.  
In view of the differential in fetal weight and PAT mass between the two stages of pregnancy and 
the dominant influence of gestational age on mRNA abundance of the majority of genes quantified, the 
relationships between fetal weight, PAT mass, metabolic status and adipose tissue gene expression were 
examined separately for the d89 and d130 groups (Table 4). At d89, the relative expression of genes 
involved in adipocyte differentiation and function, namely PPARG, G3PDH, LPL, FASN, HSL, leptin and 
UCP1, were positively related to both absolute and fetal weight-specific PAT mass, but unrelated to fetal 
weight (Table 4, Figure 3). Of the genes putatively involved in adipocyte proliferation, only IGF1 was 
weakly positively related to fetal weight-specific PAT mass. Also at d89, fetal plasma glucose was 
unrelated to abundance of any of the genes measured but fetal plasma insulin was modestly negatively 
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associated with LPL, FASN, HSL and UCP1 mRNA expression. In contrast, at gestational d130 there 
were relatively weak negative relationships between fetal size, absolute PAT mass and gene expression 
for G3PDH and HSL (Table 4). Fetal weight-specific PAT mass was positively associated with UCP1 
gene expression and was the only relationship detected at both stages of gestation. UCP1 gene expression 
and carcass fat percentage were positively associated at d130 (r=0.559, n=14, P=0.039). Fetal plasma 
glucose was positively related to leptin and all four IGF system genes at d130 and positive relationships 
were evident between fetal plasma insulin and both leptin and IGF1 gene expression.  
PRLR gene expression was unrelated to fetal weight, adiposity or metabolic status at both stages 
of gestation (not shown). Similarly PRLR mRNA abundance was not related to expression of any of the 
other genes measured in PAT. The relationships between the other 11 genes measured at gestational d89 
and 130 are detailed in Table 5. At d89, robust positive relationships were evident between all possible 
comparisons (n=21) of PPARG, G3PDH, LPL, FASN, HSL, leptin and UCP1 mRNA expression. At 
d130, similar relationships were evident between PPARG, G3PDH, LPL and HSL but none of these genes 
was related to FASN, UCP1 or leptin expression and the latter genes were not correlated with each other.  
Similarly, IGF1 and IGF2 gene expression was positively related to the various genes involved in 
adipocyte differentiation and function at d89 (reaching significance in 13 of 14 comparisons, Table 5) but 
was unrelated to these genes at d130. Selected examples of these relationships are detailed in Figure 4. 
 
Adiposity and gene expression in relation to fetal sex 
An effect of sex per se on absolute or fetal weight-specific PAT mass was not detected at either 
gestational d89 or 130 (P>0.3, data not shown). In late gestation, females had relatively more unilocular 
fat mass than males (3.2±0.34 versus 2.4±0.32g/kg) but this was not statistically significant (P=0.143). In 
relation to PAT gene expression, when sex was included as an additional factor in the ANOVA, females 
overall had greater leptin expression than males (P=0.001, Figure 2a) and the impact of maternal nutrition 
as well as gestational age was significant (P=0.029 and P=0.001, respectively). Sex also influenced PAT 
LPL gene expression (females>males, Figure 2b) and gene expression for both leptin and LPL was lower 
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in female but not male UN versus C fetuses at gestational d89 only (Figure 2a, b). Although an effect of 
sex was not detected for any of the other genes measured, PPARG mRNA expression was lower in UN 
versus C female fetuses at d89 (nutrition x stage x gender interaction, P=0.011).   
  
Discussion 
This study reveals that a number of genes regulating prenatal adipose tissue development and 
function are expressed by mid-gestation when they are already sensitive to maternal undernutrition, and 
that their expression levels are markedly changed by late gestation. The early molecular sensitivity to 
poor nutrient supply may underlie the reduced fetal adiposity and altered proportions of unilocular and 
multilocular adipocytes evident by late pregnancy. In addition, the study indicates that some sex-specific 
differences in adipose tissue gene expression may emerge in utero. 
 
Fetal growth and adiposity 
Limiting maternal intake throughout gestation in young adolescent sheep results in gradual 
depletion of maternal reserves and slowing of fetal growth. By late gestation the fetuses are lighter and 
leaner than optimally-nourished controls reflected by lower carcass fat and reduced fetal PAT mass 
(Luther et al. 2007). Herein, we demonstrate that the PAT mass reduction is primarily due to lower 
numbers of unilocular adipocytes, suggesting that limiting maternal and hence fetal nutrient supply 
restricts the development of cells primarily involved in fat storage rather than the cells involved in 
neonatal thermogenesis. The positive relationship between PAT unilocular fat mass and carcass fat 
content implies a similar scenario is likely to operate throughout the fetus leading to a lean body 
phenotype. However, while the impact of maternal undernutrition on weight at birth is statistically 
significant in our model the effect is modest and previous studies using an equivalent prenatal nutritional 
insult have failed to detect persistent influences on postnatal growth or glucose metabolism up to 6 
months of age (Wallace et al. 2010, 2012).  
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In this study a positive correlation between multilocular fat mass and fetal weight was observed 
within the undernourished group and furthermore those fetuses had more multilocular than unilocular 
adipocytes, which may be indicative of developmental delay. Nevertheless relative to the control group 
maternal undernutrition did not influence absolute or relative multilocular cell mass overall, suggesting 
that had these pregnancies progressed to term neonatal thermogenesis might not have been severely 
compromised. Indeed in two such studies no neonatal mortality occurred in offspring of undernourished 
dams following spontaneous delivery at term (Wallace 2011). 
 In our undernourished paradigm we restrict maternal intake throughout gestation rather than 
during specific “windows” as this reflects the most common scenario in human pregnancy. We also focus 
on adolescents because insufficient gestational weight gain (a proxy for maternal undernutrition) in this 
age group predicts low birthweight (Hediger et al. 1989; Scholl et al. 1991; Stevens-Simon & 
McAnarney 1992) and in developing countries where malnutrition predominates high pregnancy rates are 
commonplace in adolescents. As such there is a lack of directly comparable data in other precocial animal 
models.  
Previous studies of adipose tissue development have largely involved adult ewes undernourished 
during discrete windows of gestation, with little consensus on the impact on fetal weight or PAT mass 
(Symonds et al. 1998; Bispham et al. 2003; Budge et al. 2004; Lie et al. 2013). None of these studies 
involving undernutrition quantified adipocyte cell populations, but conversely when fetal nutrient supply 
in normal late gestation pregnancies was increased by a 10-day intrafetal glucose infusion, the unilocular 
fat mass was enhanced and the size of the dominant lipid locule was positively correlated with fetal 
glucose concentrations (Mühlhäusler et al. 2005). The latter study and the data herein suggest that 
unilocular adipocytes within the PAT depot are sensitive to the prevailing nutrient supply in utero and 
when this supply is compromised multilocular cells predominate.  
 
Perirenal fat gene expression: ontogeny and impact of undernutrition 
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The design herein allowed us to examine for the first time both the ontogeny of fetal PAT gene 
expression and the impact of maternal undernutrition. At mid-gestation when the adipose tissue first 
appears and begins to replicate, the abundance of all four IGF system genes was high, commensurate with 
the roles of IGF1 and IGF2 in adipocyte proliferation and differentiation (Holly et al. 2006; Kleiman et 
al. 2013). Moreover at this early stage of PAT development the relative gene expression of all four IGF 
system genes was already lower in undernourished fetuses, prior to any significant reduction in fetal body 
weight or PAT mass. These observations are consistent with attenuated IGF-mediated adipocyte 
proliferation and differentiation around mid-gestation most likely underlying the reduced mass and 
structural characteristics of PAT observed in the undernourished fetuses in late gestation. Although the 
consequences for postnatal body composition have not been established in this model, it is likely that the 
reduction in adipocyte number translates into increased susceptibility for cellular hypertrophy in later life 
(Heilbronn et al. 2004), particularly if the animal is exposed to a nutrient-rich diet postnatally.   
IGF1 regulates transcription factors including PPARG (Scavo et al. 2004) and attenuated local 
IGF secretion within the developing PAT of undernourished fetuses may underlie the lower expression of 
PPARG at mid-gestation, with consequences for the progression of adipocyte differentiation and function. 
From the present data it is unlikely that deficits in glucose supply directly influence PPARG expression 
because fetal plasma glucose was not different between groups in mid-gestation and no correlation 
between fetal glucose and PPARG mRNA was observed. In contrast, when maternal nutrition was 
increased in late pregnancy (55% above maintenance), fetal plasma glucose and PAT PPARG mRNA 
were  increased and positively correlated with each other, independent of changes in PAT mass or 
morphology (Mühlhäusler et al. 2007). IGF gene expression was not measured in the latter study but it is 
noteworthy that herein fetal glucose was positively related to IGF system mRNA in late pregnancy.  
Herein, the gene expression of PPARG modestly increased with gestational age. A similar 
ontogenic increase in PPARG expression has recently been reported in normally-growing ovine fetuses 
sampled at either gestational d80 or 140 (Pope et al. 2014), commensurate with its role as a key regulator 
of adipose tissue-specific genes and with the increase in PAT mass as gestation proceeds. Accordingly a 
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marked increase in relative gene expression between mid and late gestation was observed here for 
selected genes involved in lipid deposition, metabolism and signalling (G3PDH, HSL, leptin), whereas 
others involved in fatty acid synthesis and uptake into adipocytes (FASN, LPL) were surprisingly 
independent of gestational age.  
For the genes specific to brown adipose tissue, namely PRLR and UCP1, abundance was 
extremely low in mid-pregnancy and high at late pregnancy in line with their role in promoting adequate 
thermogenesis after birth (Symonds et al. 1998; Pearce et al. 2005). Furthermore, the absence of an effect 
of maternal undernutrition on PRLR and UCP1 gene expression in the present late gestation fetuses 
matched the lack of effect on multilocular adipocyte mass. Conversely, the trend for attenuated PAT gene 
expression in UN fetuses for leptin, a white adipose tissue-specific gene (Yuen et al. 2003), was in line 
with the observed reduction in unilocular cell mass in late gestation. 
Irrespective of the direction of ontogenic change, and with the exception of the aforementioned 
leptin expression, it is noteworthy that none of the other genes measured were impacted only in late 
gestation by maternal undernutrition, indicating that key molecular events underlying the lean fetal 
phenotype in this model originated earlier in gestation. In support we observed robust positive 
correlations between fetal weight-specific PAT mass and genes involved in adipocyte differentiation and 
function at gestational d89 (PPARG, G3PDH, LPL, FASN, HSL, leptin and UCP1), but by late gestation 
only a weak relationship between UCP1 and adiposity persisted. Moreover, expression of IGF1 and IGF2 
and all the aforementioned genes were highly correlated with each other at the early stage of gestation, 
but fewer between-gene relationships were evident by late gestation. These findings may be attributable 
to differentiation of adipose tissue into the two main cell types by late gestation, and the relative 
proportion of white versus brown adipocytes being differentially impacted by maternal undernutrition by 
that stage.  
 
Perirenal fat gene expression: impact of sex 
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We did not originally power the study to examine gender effects as we had no control over the sex 
of the embryo at the time of its transfer into the adolescent recipient. Irrespective of the low power when 
the gene expression data were examined it became clear that potentially interesting sex-specific effects 
were emerging. Accordingly when sex was included as a factor in the analysis, both leptin and LPL gene 
expression was higher in females than males overall. This agrees with reported higher LPL abundance in 
PAT and subcutaneous fat depots in female versus male lambs at 4 months postnatal age (Rattanatray et 
al. 2010). It also matches our data showing widespread sex differences in PAT gene expression, namely 
higher LPL, FASN and leptin, and lower IGF1, IGF2 and HSL in females, corresponding with their 
greater visceral and carcass fat deposition and larger adipocytes at 3 months of age (Wallace et al. 2014). 
Thus, the present study is the first in sheep to suggest that sex-specific differences in molecular markers 
of adipose tissue differentiation and/or function emerge in utero. We acknowledge that these potentially 
interesting gender differences in PAT gene expression require to be substantiated in a larger and more 
suitably powered study.  Nevertheless greater expression of leptin in female fetal PAT aligns with the 
prenatal sexual dimorphism in leptin secretion and neonatal adiposity in humans (females> males). 
Relative to males, female gender is associated with greater leptin concentrations in amniotic samples at 
16 weeks gestation and in cord blood at delivery (Cagnacci et al. 2006; Kayemba-Kay’s et al. 2008), and 
with greater percentage body fat as measured by air-displacement plethysmography neonatally (Hawkes 
et al. 2011).  Furthermore, since only females were sensitive herein to the effects of maternal 
undernutrition with respect to PPARG, leptin and LPL gene expression at gestational d89, the implication 
is that sensitivity to prevailing nutrition occurs earlier in females than males and there is likely to be a 
temporal difference in adipose tissue development between sexes throughout the early life-course. 
Previous studies investigating the impact of maternal nutrition on prenatal adipose gene 
expression in precocial animals have not reported fetal sex (Bispham et al. 2003; Budge et al. 2004; 
Mühlhäusler et al. 2007; Nguyen et al. 2010; Lie et al. 2013) but it is clearly an important consideration; 
imbalances in the male:female ratio may have confounded earlier results and may explain the lack of 
consensus in the sheep literature. Indeed, sexually-dimorphic differences in fetal growth and expression 
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of genes involved in adipogenesis and brown adipose tissue development following in vitro adipocyte 
differentiation in culture are seen in fetal baboons following modest maternal undernutrition throughout 
gestation (Tchoukalova et al. 2014). Although we did not determine the long term impact of the mid-
gestation sex-specific nutritional sensitivity of adipose tissue gene expression on postnatal adiposity, the 
present data align with findings from the Dutch famine of 1945. These show that maternal famine 
exposure during early (but not mid or late) pregnancy is associated with greater BMI and waist 
circumference at age 50 in women but not men (Ravelli et al. 1999) and may be due to altered DNA 
methylation of genes involved in adipose tissue metabolism (Tobi et al. 2009). 
In conclusion, these data support the hypothesis that molecular markers of adipose tissue 
development in the fetus are temporally sensitive to maternal undernutrition in precocial mammals. Some 
key genes regulating adipose tissue development and function are active from mid-gestation when they 
are variously sensitive to maternal undernutrition leading to reduced fetal adiposity in late gestation. 
Furthermore, sex-specific differences in adipose tissue gene expression emerge in fetal life. Whether 
these prenatal events impact body composition in adult life remains unknown but it is clear that ensuring 
adequate maternal nutrition from the earliest stages of pregnancy is essential to optimise fetal growth and 
neonatal adipose development.  
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Figure Legends 
 
Figure 1. Haematoxylin and eosin-stained sections of perirenal fat from a representative fetus from a 
control and an undernourished pregnancy (both females) with unilocular and multilocular fat cells 
highlighted (a and b), and relationships between perirenal unilocular fat mass and percentage of fat in the 
carcass (c, r=0.806, P=0.001), and between fetal weight and multilocular fat mass (d, r=0.605, P=0.022) 
at day 130 of gestation in fetuses from control (□) and undernourished (■) adolescent dams. 
 
Figure 2. Relative leptin (a) and LPL (b) mRNA expression in fetal perirenal fat of female (solid bar) and 
male (open bar) fetuses from control (C) and undernourished (UN) adolescent dams whose pregnancies 
were terminated on day 89 or day 130 of gestation. ANOVA was used to determine effects of sex, 
maternal nutrition, stage of gestation, and all possible interactions. Vertical bars are group mean ± sem 
and those with different letters differ P<0.05 using Tukey’s post-hoc method. Number of fetuses per 
group can be derived from Table 3. For leptin, there were effects of gender (P=0.001), stage of gestation 
(P=0.001), nutrition (P=0.029) and a gender x nutrition interaction (P=0.029). For LPL, there was an 
effect of gender (P=0.002), and a gender x nutrition x stage of gestation interaction (P=0.008).   
 
Figure 3. Relationships between body weight-specific perirenal adipose tissue (PAT) mass and perirenal 
fat (a) LPL mRNA (r=0.795, P<0.001) and (b) leptin mRNA (r=0.872, P<0.001) at day 89 of gestation in 
fetuses from control (□) and undernourished (■) adolescent dams. 
 
Figure 4. Relationships between relative PPARG gene expression and (a) IGF1, (b) G3PDH, (c) LPL and 
(d) leptin mRNA in fetal perirenal adipose tissue (PAT) at day 89 (●) and 130 (○) of gestation. At day 89 
and 130, respectively: r=0.940, P<0.001 and r=0.118, not significant (NS) for (a); r=0.853, P<0.001 and 
r=0.653, P<0.05 for (b); r=0.910, P<0.001 and r=0.723, P<0.01 for (c); r=0.900, P<0.001 and r=0.242, 
NS for (d). 
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Table 1. Maternal and fetal phenotype at necropsy on day 89 and 130 of gestation in relation to maternal nutrition (n=7/group) 
Stage of Gestation Day 89 Day 130 P valueα 
Maternal Nutrition Control UN Control UN Stage Nutrition Interaction 
Maternal  
     Change in adiposity§ 
     Liveweight, Kg¥ 
 
0.0±0.0a 
46.4±0.67a 
 
-0.4±0.05b 
42.3±1.12b 
 
0.0±0.0a 
49.6±0.58a 
 
-0.7±0.06c 
41.3±0.93b 
 
0.001 
0.236 
 
0.000 
0.000 
 
0.001 
0.024 
     Carcass weight, Kg 23.4±0.48a 20.5±0.71b 24.8±0.60a 18.9±0.53b 0.769 0.000 0.019 
     Plasma glucose, µmol/l 3.18±0.125a 2.99±0.055ab 3.29±0.098a 2.75 ±0.062b 0.484 0.000 0.057 
     Plasma insulin, ng/ml 0.69±0.058a 0.53±0.031ab 0.75±0.090a 0.39±0.046b 0.481 0.000 0.127 
     Plasma NEFA, mmol/ml 0.30±0.077a 0.26±0.039a 0.38±0.051ab 0.76±0.187b 0.012 0.129 0.063 
Fetal  
  Weight, g 
 
657±30a 
 
597±43a 
 
4274±84b 
 
3555±152c 
 
0.000 
 
0.000 
 
0.002 
  Total placentome weight, g 665±75a 607±28ab 480±28b 469±39b 0.002 0.595 0.751 
  Brain: liver ratio 0.314±0.017a 0.359±0.020ab 0.313±0.025a 0.441±0.031b 0.107 0.003 0.101 
  Plasma glucose, µmol/l 0.49±0.038a 0.47±0.055a 0.39±0.076ab 0.22±0.030b 0.004 0.076 0.150 
  Plasma insulin, ng/ml 0.44±0.022 0.44±0.019 0.47±0.083 0.29±0.038 0.215 0.076 0.086 
  Perirenal fat weight, g 2.1±0.29a 1.45±0.33a 27.4±1.11b 19.5±1.01c 0.000 0.000 0.000 
  Perirenal fat, g/kg fetus  3.3±0.52a 2.3±0.34a 6.4±0.23b 5.5±0.33b 0.000 0.019 0.890 
Values are group mean ± sem. αPost-hoc comparisons (Tukey’s Method) used to further differentiate between four groups  
thus within rows values with a different superscript letter differ at P<0.05. §Change in external adiposity score from embryo transfer  
to necropsy ¥Liveweight minus weight of gravid uterus at necropsy. UN, undernourished; NEFA, non-esterified fatty acids 
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Table 2. Unilocular and multilocular adipose cell distribution in the fetal perirenal  
fat depot at day 130 of gestation in relation to maternal nutrition (n=7/group) 
Maternal Nutrition Control UN P value, C vs UN 
Unilocular fat 
   Volume density, % 
 
51.3±3.79 
 
41.9±4.47* 
 
0.137 
   Total mass, g 14.0±1.07 8.2±1.01¥ 0.002 
   Relative mass, g/kg fetus 3.3±0.26 2.4±0.37 0.078 
Multilocular fat 
   Volume density, % 
 
48.6±3.81 
 
58.0±4.47* 
 
0.135 
   Total mass, g 13.4±1.37 11.3±0.96¥ 0.231 
   Relative mass, g/kg fetus 3.1±0.29 3.1±0.18 0.954 
Values are group mean ± sem. UN, undernourished. Within a nutritional group  
values with the same symbol differ from each other, P<0.05.  
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Table 3. Fetal perirenal fat gene expression at necropsy on day 89 and 130 of gestation in relation to 
maternal nutrition (n=7/group) 
 
Stage of Gestation Day 89 Day 130 P value α 
Maternal Nutrition Control UN Control UN Stage Nutrition Interaction 
Male: female ratio 3:4 2:5 3:4 3:4    
18S 0.023±0.001 0.024±0.001 0.024±0.001 0.024±0.001 0.551 0.214 0.150 
PPARG/18S 20.6±1.89ab 15.6±1.15a 22.3±1.25b 23.8±1.49b 0.003 0.266 0.042 
G3PDH/18S 20.9±2.21a 18.8±1.47a 41.9±2.95b 50.8±3.29b  0.000 0.213 0.051 
LPL/18S 27.6±4.11 20.8±1.71 24.8±1.96 26.8±2.73 0.578 0.415 0.142 
FASN/18S 22.6±3.95 21.2±2.47 27.4±3.57 20.9±2.00 0.973 0.433 0.423 
HSL/18S 10.6±2.09a 7.7±0.87a 36.9±1.48b 43.5±3.41b 0.000 0.423 0.047 
Leptin/18S 34.9±5.97ab 23.8±1.88b 47.9±5.08a 40.3±3.96ab 0.004 0.056 0.708 
UCP-1/18S 0.53±0.07a 0.38±0.08a 37.3±3.05b 33.9±2.94b 0.000 0.431 0.469 
PRLR/18S 0.9±0.12a 0.9±0.15a 25.6±3.26b 26.1±2.84b 0.000 0.905 0.901 
IGF1/18S 30.5±1.48a 23.1±1.83a 10.9±3.30b 5.9±0.32b 0.000 0.006 0.563 
IGF2/18S 35.3±2.36a 27.0±2.49a 9.0±2.76b 7.1±0.41b 0.000 0.031 0.163 
IGF1R/18S 14.6±1.10a 11.8±1.12ab 8.9±0.50b 8.4±0.64b 0.000 0.082 0.204 
IGF2R/18S 21.8±1.57a 16.1±1.67b 8.1±1.18c 7.5±0.68c 0.000 0.025 0.067 
Values are group mean ± sem. αPost-hoc comparisons (Tukey’s Method) used to further differentiate between  
the four groups; thus within rows values with a different superscript letter differ at P<0.05. UN, undernourished. 
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Table 4. Relationship between perirenal fat gene expression (relative to 18S) and fetal weight, fat mass and metabolic status at day 89  
and 130 of gestation, irrespective of maternal nutrition and gender.  
 PPARG G3PDH LPL FASN HSL Leptin UCP-1 IGF1 IGF2 IGF1R IGF2R 
Day 89 
  Fetal weight, g 
 
0.137 
 
0.139 
 
0.161 
 
0.333 
 
0.274 
 
0.122 
 
0.203 
 
0.257 
 
0.189 
 
-0.132 
 
0.066 
  Perirenal fat mass, g 0.619* 0.636* 0.707** 0.807*** 0.770*** 0.759** 0.630* 0.505 0.389 -0.060 0.325 
  Perirenal fat, g/kg fetus 0.729** 0.717** 0.795*** 0.808*** 0.805*** 0.872*** 0.702** 0.558* 0.442 0.049 0.420 
  Plasma glucose -0.207 -0.282 -0.233 -0.177 -0.166 -0.215 -0.397 -0.105 -0.075 -0.323 -0.234 
  Plasma insulin -0.497 -0.413 -0.584* -0.538* -0.696** -0.489 -0.697** -0.377 -0.436 -0.205 -0.400 
Day 130 
  Fetal weight, g 
 
-0.422 
 
-0.560* 
 
-0.511 
 
0.239 
 
-0.612* 
 
0.015 
 
0.003 
 
0.390 
 
0.093 
 
-0.061 
 
-0.047 
  Perirenal fat mass, g -0.328 -0.570* -0.315 0.193 -0.549* 0.179 0.421 0.483 0.267 0.093 0.140 
  Perirenal fat, g/kg  fetus -0.064 -0.315 0.010 0.084 -0.222 0.208 0.594* 0.343 0.295 0.161 0.221 
  Plasma glucose 0.172 0.215 0.197 0.361 -0.130 0.689** 0.265 0.879***  0.796** 0.631* 0.741** 
  Plasma insulin -0.059 -0.137 0.129 0.016 -0.241 0.716** 0.192 0.597* 0.477 0.449 0.475 
Values are Pearson correlation coefficients with significant values shown in bold, *P<0.05, **P<0.01, ***P<0.001. 
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Table 5. Relationships between relative expression of genes in perirenal fat irrespective of nutrition status or gender at  
day 89 and day 130 of gestation 
Day 89 G3PDH LPL FASN HSL Leptin UCP1 IGF1 IGF2 IGF1R IGF2R 
PPARG 0.853*** 0.910*** 0.715** 0.747** 0.900*** 0.768** 0.940*** 0.896*** 0.593* 0.882*** 
G3PDH  0.754** 0.677** 0.693** 0.845*** 0.715** 0.710** 0.738** 0.429 0.670** 
LPL   0.899*** 0.891*** 0.938*** 0.754** 0.805*** 0.714** 0.361 0.738** 
FASN    0.896*** 0.833*** 0.669** 0.573* 0.468 -0.023 0.422 
HSL     0.868*** 0.837*** 0.603* 0.560* 0.124 0.515 
Leptin      0.752** 0.735** 0.662** 0.311 0.666** 
UCP1       0.663** 0.626* 0.333 0.599* 
IGF1        0.951*** 0.686** 0.927*** 
IGF2         0.776*** 0.937** 
IGF1R          0.874*** 
Day 130 G3PDH LPL FASN HSL Leptin UCP-1 IGF1 IGF2 IGF1R IGF2R 
PPARGγ 0.653* 0.723** 0.157 0.824*** 0.242 0.171 0.118 0.345 0.548* 0.427 
G3PDH  0.645* 0.189 0.713** 0.347 -0.113 0.192 0.356 0.252 0.321 
LPL   -0.008 0.716** 0.222 0.006 0.014 0.155 0.502 0.245 
FASN    0.099 0.129 -0.047 0.348 0.337 0.000 0.193 
HSL     0.220 -0.217 -0.166 0.087 0.181 0.150 
Leptin      0.107 0.433 0.432 0.506 0.501 
UCP1        0.390 0.446 0.419 0.423 
IGF1        0.934*** 0.509 0.768*** 
IGF2         0.598* 0.896*** 
IGF1R          0.816*** 
Values are Pearson correlation coefficients with significant values shown in bold, *P<0.05, **P<0.01, ***P<0.001. 
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Figure 1 – see separate file 
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Figure 3. 
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Figure 4 
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